Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Other Current Assets
ÂĄ108.6m
CAGR 3-Years
26%
CAGR 5-Years
30%
CAGR 10-Years
10%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Current Assets
ÂĄ129.8m
CAGR 3-Years
30%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Current Assets
ÂĄ357.3m
CAGR 3-Years
-54%
CAGR 5-Years
-7%
CAGR 10-Years
24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Current Assets
ÂĄ1.8B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
24%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Current Assets
ÂĄ1B
CAGR 3-Years
-34%
CAGR 5-Years
5%
CAGR 10-Years
10%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Current Assets
ÂĄ70.3m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Current Assets?
Other Current Assets
108.6m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Other Current Assets amounts to 108.6m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
10%

Over the last year, the Other Current Assets growth was 114%. The average annual Other Current Assets growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 26% over the past three years , 30% over the past five years , and 10% over the past ten years .

Back to Top